PortViewPortView
BioLife Solutions logo

BioLife Solutions (BLFS) Stock Analysis

NASDAQHealthcareMedical - Instruments & Supplies

$38.61+0.00%
1-year price historyRange $18.15 – $39.22
52-week range$38.61
$17.86$39.76

Track BLFS in your portfolio for free · Portfolio tracker

What BioLife Solutions does

BioLife Solutions, Inc. (BLFS) operates as a global provider of specialized bioproduction tools and services, primarily catering to the cell and gene therapy industry. Its market reach extends across the United States, Canada, Europe, the Middle East, Africa, and other international regions. The company's offerings are essential for various stages of biologic-based therapy development, spanning from foundational and applied research to large-scale commercial manufacturing. Key products include proprietary biopreservation media, such as HypoThermosol FRS and CryoStor, which are engineered to minimize delayed cell damage and death typically associated with preservation. Complementing these are the ThawSTAR products, an automated line of devices for thawing vials and cryobags, designed to precisely manage the heat and timing for optimal biologic material thawing. BLFS also provides innovative cloud-connected evo shipping containers for the passive storage and secure transport of temperature-sensitive biologics and pharmaceuticals. Additionally, its comprehensive range encompasses liquid nitrogen laboratory freezers, various cryogenic equipment and accessories, and specialized storage services for biological and pharmaceutical products. Products are distributed both directly to customers and through a network of third-party distributors. Established in 1987, BioLife Solutions, Inc. maintains its headquarters in Bothell, Washington.

Key metrics

Market cap
$1.89B
P/E (TTM)
37.49
EPS (TTM)
$1.03
Beta
1.92
Dividend yield
0.00%
Revenue / share
$2.10
50-day avg
$35.70
200-day avg
$26.62
52-week high
$39.76
52-week low
$17.86
CEO
Roderick de Greef

ETFs linked to BLFS

Broad-market and Healthcare sector ETFs an investor holding BioLife Solutions is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how BLFS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze BLFS in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for BioLife Solutions?
BioLife Solutions trades under the ticker BLFS on NASDAQ.
Which exchange is BLFS listed on?
BLFS is listed on NASDAQ.
What sector does BioLife Solutions operate in?
BioLife Solutions is classified in the Healthcare sector (Medical - Instruments & Supplies industry).
How can PortView help analyze BLFS in a portfolio?
PortView shows BLFS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.